Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024 0

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024 0

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024 19

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024 19

Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on: February 23,2024 14

Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on:February 23,2024 14

Swapping meat for 'mycoprotein' may protect against bowel cancer

by Northumbria UniversityVegetarian chilli con carne made with Quorn mycoprotein. Credit: QuornResearchers from Northumbria University have found that swapping red and processed meat for Quorn&#3

Updated on: February 23,2024 17

Swapping meat for 'mycoprotein' may protect against bowel cancer

by Northumbria UniversityVegetarian chilli con carne made with Quorn mycoprotein. Credit: QuornResearchers from Northumbria University have found that swapping red and processed meat for Quorn&#3

Updated on:February 23,2024 17

Study: Two drugs prevent heart problems in breast cancer patients

by University of KentuckyDr. Maya Guglin chaired a study demonstrating the effectiveness of beta blockers and ACE inhibitors to prevent cardio toxicity in certain breast cancer patients. Credit:

Updated on: June 28,2024 4

Study: Two drugs prevent heart problems in breast cancer patients

by University of KentuckyDr. Maya Guglin chaired a study demonstrating the effectiveness of beta blockers and ACE inhibitors to prevent cardio toxicity in certain breast cancer patients. Credit:

Updated on:June 28,2024 4

No 'smoking gun' mental health harm from internet: Study

by University of OxfordCredit: CC0 Public DomainLinks between internet adoption and psychological well-being are small at most, despite popular assumptions about the negative psychological effect

Updated on: June 28,2024 5

No 'smoking gun' mental health harm from internet: Study

by University of OxfordCredit: CC0 Public DomainLinks between internet adoption and psychological well-being are small at most, despite popular assumptions about the negative psychological effect

Updated on:June 28,2024 5

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on: April 01,2024 16

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D

Updated on:April 01,2024 16

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on: March 06,2024 14

AI predicts cancer patients' symptoms

by University of SurreyCredit: CC0 Public DomainDoctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to predict symptoms and their se

Updated on:March 06,2024 14

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex

Updated on: March 06,2024 20

Major breakthrough in quest for cancer vaccine

by University of MontrealCredit: CC0 Public DomainThe idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove ex

Updated on:March 06,2024 20

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the

Updated on: January 30,2024 12

A new method for conducting a liquid biopsy for liver cancer

by Bob Yirka , Medical XpressComparison between mutation and methylation fractions in the same cfDNA sample. (A) The correlation between the AF based on mutation and methylation. (B) Comparison of the

Updated on:January 30,2024 12

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on: March 30,2024 0

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on:March 30,2024 0

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024 15

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024 15